Download Sample
Add to CartCardiovascular Repair And Reconstruction Devices Market
By Product;
Heart Valve Repair, Cardiovascular Grafts [Endovascular Stent Graft, Hemodialysis Access Graft and Peripheral Vascular Graft] and Cardiovascular PatchesBy Application;
Cardiac Repair Patches [Atrial Septal Defect, Common Atrium, Defects of the Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot and Suture Bleeding], Vascular Repair Patches [Carotid Endarterectomy, Anomalous Connection of the Pulmonary Veins, Transportation of the Great Vessels and Reconstruction of the Portal & Superior Mesenteric Veins] and OthersBy Raw Material;
Synthetic Patches and Biological PatchesBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Cardiovascular Repair And Reconstruction Devices Market Overview
Cardiovascular Repair And Reconstruction Devices Market (USD Million)
Cardiovascular Repair And Reconstruction Devices Market was valued at USD 3,849.86 million in the year 2024. The size of this market is expected to increase to USD 5,574.35 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.4%.
Cardiovascular Repair And Reconstruction Devices Market
*Market size in USD million
CAGR 5.4 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 5.4 % |
| Market Size (2024) | USD 3,849.86 Million |
| Market Size (2031) | USD 5,574.35 Million |
| Market Concentration | Medium |
| Report Pages | 316 |
Major Players
- YNOVIS MICRO COMPANIES ALLIANCE, INC
- Admedus Ltd
- St Jude Medical
- Reverse Medical Corporation
- Terumo Medical Corporation
- MAQUET Cardiovascular, LLC
- CorMatrix
- LeMaitre Vascular, Inc
- Edwards Lifesciences Corporation
- Cryolife
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Cardiovascular Repair And Reconstruction Devices Market
Fragmented - Highly competitive market without dominant players
The cardiovascular repair and reconstruction devices market continues to expand due to the rising incidence of heart-related conditions and the growing volume of surgical interventions. A significant portion of cardiac procedures now depend on these devices for structural support and recovery. In fact, over 55% of cardiovascular surgeries incorporate these tools, emphasizing their integral role in modern treatment protocols.
Innovation Driving Material Advancements
Ongoing technological advancements are transforming the way cardiovascular repair is approached. With innovations such as bioengineered materials and durable synthetic grafts, patient outcomes have significantly improved. Around 40% of new devices utilize biocompatible or bioresorbable elements, which promote better healing and integration within the body’s tissue framework.
Surge in Minimally Invasive Solutions
There is a marked increase in the use of minimally invasive cardiovascular repair devices. These options are preferred for their reduced post-operative complications and quicker recovery. Currently, about 48% of cardiac repair procedures are performed using less invasive device options, showcasing a preference for techniques that enhance patient comfort without compromising efficacy.
Tailored Devices Gaining Ground
Personalized healthcare is influencing the design of custom-fit cardiovascular devices. Leveraging advancements in 3D printing and digital modeling, manufacturers are now producing grafts and patches that meet the unique needs of individual patients.
Broader Clinical Adoption and Market Growth
The market is steadily expanding as healthcare institutions prioritize advanced surgical tools to handle complex cardiovascular conditions. With more than 50% of top-tier hospitals now integrating these devices into their cardiac units, the landscape is becoming increasingly competitive and innovation-driven. The emphasis on high-performance surgical aids continues to fuel demand and adoption.
Cardiovascular Repair And Reconstruction Devices Market Key Takeaways
-
Minimally invasive solutions expand, with transcatheter heart valves, ePTFE patches, and grafts offering faster recovery and reduced complications in cardiovascular treatments.
-
Regenerative technologies advance, as biodegradable valves and biomaterials gain traction for long-term adaptability, especially in congenital heart conditions.
-
R&D investments rise, focusing on improving endovascular devices and precision tools to address complex arterial and structural heart diseases.
-
Funding boosts innovation, with multi-million-dollar investments supporting next-generation transcatheter valve repair and reconstruction technologies.
-
Collaborative partnerships grow, with companies teaming up to enhance physician training and expand access to advanced cardiovascular care in underserved regions.
-
Biomaterial breakthroughs strengthen, as advanced patches, valves, and grafts improve durability, integration, and overall patient outcomes.
-
Adoption accelerates, led by North America’s infrastructure strength while Asia-Pacific experiences rapid growth from aging populations and rising healthcare access.
Cardiovascular Repair And Reconstruction Devices Recent Developments
-
On June 12, 2024, Teijin Medical Technologies launched Synfolium, a novel cardiovascular surgical patch developed for congenital heart procedures. This innovative biomaterial enhances surgical precision, biocompatibility, and recovery outcomes, marking a significant advancement in pediatric and cardiovascular medical applications.
-
On August 20, 2024, Edwards Lifesciences completed the acquisition of JC Medical, obtaining its intellectual property and commercial rights for the J-Valve transcatheter aortic valve system. This strategic move expands Edwards’ structural heart portfolio, enhancing treatment options for aortic regurgitation repair and replacement procedures.
Cardiovascular Repair And Reconstruction Devices Market Segment Analysis
In this report, the Cardiovascular Repair And Reconstruction Devices Market has been segmented by Product, Raw Material, Application, End User and Geography.
Cardiovascular Repair And Reconstruction Devices Market, Segmentation by Product
The Cardiovascular Repair And Reconstruction Devices Market has been segmented by Product into Heart Valve Repair And Cardiovascular Graft – [Endovascular Stent Graft, Hemodialysis Access Graft And Peripheral Vascular Graft], Cardiovascular Patches – [Cardiac Repair Patches, Atrial Septal Defect (Secundum), Common Atrium, Defects Of The Endocardial Cushion, Ventricular Septal Defect (VSD), Tetralogy Of Fallot, RVOT Reconstruction And Suture Bleeding], Vascular Repair Patches – [Carotid Endarterectomy, Anomalous Pulmonary Venous Connection, Transposition Of The Great Vessels (Mustard Operation), Reconstruction Of Portal And Superior Mesenteric Veins, Other Vascular Repair And Reconstruction (Femoral, Renal, Iliac And Tibial Blood Vessels)].
Heart Valve Repair and Cardiovascular Graft
The heart valve repair and cardiovascular graft segment leads the global market with an estimated 45–50% share. It includes devices such as endovascular stent grafts, hemodialysis access grafts, and peripheral vascular grafts, which are essential for procedures involving aortic aneurysm repair, vascular access for dialysis, and peripheral artery disease. Rising incidences of vascular occlusion, valvular degeneration, and increased preference for minimally invasive techniques are driving demand.
Cardiovascular Patches
Holding about 30–35% of the market, cardiovascular patches are widely used in congenital and acquired cardiac repairs. These include patches for conditions such as atrial septal defect (Secundum), common atrium, endocardial cushion defects, ventricular septal defect (VSD), Tetralogy of Fallot, RVOT reconstruction, and suture bleeding control. Growth in pediatric cardiac surgeries and advances in bioabsorbable and tissue-engineered materials support this segment’s expansion.
Vascular Repair Patches
Vascular repair patches contribute approximately 20–25% of the global market. These devices are used in complex vascular procedures like carotid endarterectomy, repair of anomalous pulmonary venous connection, and transposition of the great vessels (Mustard operation). Additionally, they are vital in reconstruction of mesenteric, portal, renal, iliac, femoral, and tibial vessels. Increasing cases of vascular trauma, stroke prevention, and reconstructive interventions are fueling segment growth.
Cardiovascular Repair And Reconstruction Devices Market, Segmentation by Raw Material
The Cardiovascular Repair And Reconstruction Devices Market has been segmented by Raw Material into Synthetic Patches and Biological Patches.
Synthetic Patches
Synthetic patches dominate the raw material segment with a market share of 55–60%. These patches, often composed of expanded polytetrafluoroethylene (ePTFE) and polyester, provide long-term durability, resistance to infection, and structural reliability in high-stress applications. They are the preferred choice for cardiovascular grafts and reconstructive surgeries requiring mechanical strength.
Biological Patches
Biological patches hold around 40–45% of the market and are crafted from biological tissues such as bovine or porcine pericardium or human dermis. They support natural healing, offer excellent tissue compatibility, and are often used in delicate procedures like pediatric cardiac repairs. The demand for regenerative, biodegradable materials is fueling rapid adoption of biological options.
Cardiovascular Repair And Reconstruction Devices Market, Segmentation by Application
The Cardiovascular Repair And Reconstruction Devices Market has been segmented by Application into Cardiac Repair Patches, Atrial Septal Defect, Common Atrium, Defects Of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy Of Fallot, Suture Bleeding, Vascular Repair Patches, Carotid Endarterectomy, Anomalous Connection Of The Pulmonary Veins, Transportation Of The Great Vessels, Reconstruction Of The Portal & Superior Mesenteric Veins, And Others.
Cardiac Repair Patches
Cardiac repair patches hold a substantial 25–30% share of the cardiovascular repair and reconstruction devices market. These patches play a vital role in correcting structural heart defects and supporting the heart during complex surgical procedures. They are widely adopted in both adult and pediatric cardiac surgeries, ensuring tissue compatibility and durability.
Atrial Septal Defect, Common Atrium, Endocardial Cushion Defects, Ventricular Septal Defect, Tetralogy of Fallot
This group of congenital heart defects represents 30–35% of the application segment. Surgical patches are used for septal closure and anatomical reconstruction, especially in infants and children. The rise in early diagnosis and corrective interventions is boosting the demand for advanced patch technologies.
Suture Bleeding
Suture bleeding control accounts for around 10–15% of the market. Specialized patches designed for hemostasis are used during cardiac operations to reduce blood loss and promote wound sealing. These are especially important in high-risk or minimally invasive procedures.
Vascular Repair Patches & Complex Vascular Reconstructions
Applications like carotid endarterectomy, anomalous pulmonary venous connection, transposition of the great vessels, and portal/mesenteric vein reconstruction together contribute 20–25% of the market. These involve highly specialized vascular reconstruction procedures that demand durable and conformable patch solutions.
Others
The remaining 5–10% includes niche procedures such as valvular tissue reinforcement, rare congenital corrections, and experimental hybrid approaches. Growth is supported by innovations in biomaterials, custom patch designs, and multifunctional surgical devices.
Cardiovascular Repair And Reconstruction Devices Market, Segmentation by End User
The Cardiovascular Repair And Reconstruction Devices Market has been segmented by End User into Hospitals, Independent Cardiac Catheterization Labs, and Ambulatory Surgical Centers.
Hospitals
Hospitals lead the cardiovascular repair and reconstruction devices market, accounting for 60–65% of global usage. These facilities are equipped to handle high-risk cardiac surgeries and offer round-the-clock care with access to cardiothoracic surgeons, ICUs, and hybrid operating rooms. Their ability to manage both elective and emergency procedures makes them the primary market drivers.
Independent Cardiac Catheterization Labs
Independent cardiac catheterization labs contribute about 20–25% of the market. These specialized centers focus on diagnostic imaging, angioplasty, and minimally invasive cardiac interventions. Their appeal lies in providing fast, targeted care at lower costs, especially in areas lacking large hospital infrastructure.
Ambulatory Surgical Centers
Ambulatory surgical centers (ASCs) make up roughly 10–15% of the market. ASCs are gaining popularity due to their focus on short-stay, outpatient cardiovascular procedures. Increasing investments in compact, advanced surgical tools have enabled these centers to handle selected repair and reconstruction cases safely and efficiently.
Cardiovascular Repair And Reconstruction Devices Market, Segmentation by Geography
In this report, the Cardiovascular Repair And Reconstruction Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Cardiovascular Repair And Reconstruction Devices Market Share (%), by Geographical Region
North America
North America holds the largest share of the cardiovascular repair and reconstruction devices market at 35–40%. The region’s leadership is driven by a high prevalence of cardiovascular diseases, cutting-edge surgical innovation, and strong adoption of bioengineered patches and grafts. Favorable reimbursement systems and hospital infrastructure continue to support market growth.
Europe
Europe contributes around 25–30% to global revenue, supported by robust clinical infrastructure, a rise in geriatric heart surgeries, and expanded access to reconstructive cardiac care. The region also benefits from government-funded programs promoting early diagnosis and intervention.
Asia Pacific
Asia Pacific accounts for 20–25% of the market and is projected to expand rapidly. Factors like increasing medical device approvals, expansion of tertiary care facilities, and growing awareness of pediatric heart repair options are accelerating adoption of advanced cardiovascular solutions.
Middle East and Africa
With a share of 5–8%, the Middle East and Africa region is emerging steadily. Investments in healthcare modernization, growing patient access to specialized surgical procedures, and national programs focused on non-communicable disease control are driving growth in this region.
Latin America
Latin America makes up 5–7% of the global market. Key markets like Brazil and Mexico are experiencing increased demand for cardiovascular repair solutions due to rising prevalence of valvular and congenital heart defects, and improvements in surgical training and technology adoption.
Cardiovascular Repair And Reconstruction Devices Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Cardiovascular Repair And Reconstruction Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Rising adoption of diagnostic & monitoring tools
- Prevalence of Cardiovascular Diseases
- Increasing Awareness and Diagnosis
-
Government Initiatives and Healthcare Policies - Government initiatives and healthcare policies are playing a pivotal role in driving the growth of the cardiovascular repair and reconstruction devices market. With cardiovascular diseases being a leading cause of mortality worldwide, many governments have implemented strategic health programs aimed at improving early diagnosis, access to surgical interventions, and post-operative care. These initiatives often include public funding, subsidies, and infrastructure development that support the widespread availability of advanced cardiovascular devices in public healthcare systems.
In addition to funding, supportive regulations and policy frameworks are encouraging faster approval and adoption of innovative repair and reconstruction technologies. Policies promoting minimally invasive procedures and value-based care models are further accelerating the use of devices such as vascular grafts, annuloplasty rings, and tissue patches. As national healthcare priorities continue to focus on reducing cardiovascular disease burdens, these policies are directly influencing procurement trends and reinforcing market expansion on a scale.
Restraints:
- Expensive Medical Procedure Costs
- Strict Regulatory Compliance Requirements
-
Inadequate Reimbursement Policy Support - Inadequate reimbursement policy support remains a critical restraint in the cardiovascular repair and reconstruction devices market. In many countries, especially in developing regions, reimbursement frameworks either do not cover advanced cardiovascular devices or offer limited compensation for complex procedures. This creates a financial burden on both healthcare providers and patients, discouraging the use of high-cost, technologically advanced devices despite their clinical effectiveness.
Even in developed markets, reimbursement inconsistencies across regions and payers contribute to uncertainty and limited access. Hospitals and surgical centers may hesitate to adopt innovative repair and reconstruction solutions if reimbursement does not adequately reflect the cost of device procurement, surgical time, and post-operative care. This lack of financial incentive can hinder broader implementation, slow market growth, and prevent patients from benefiting from cutting-edge cardiovascular technologies.
Opportunities:
- Surge in minimally invasive & outpatient procedures
- Focus on Patient-Centric Approaches
- Collaborations and Partnerships
- Telemedicine and Remote Monitoring
-
Shift towards Value-Based Healthcare - Shift towards value-based healthcare is creating compelling opportunities in the cardiovascular repair and reconstruction devices market. Healthcare systems across the world are increasingly transitioning from volume-driven models to frameworks that prioritize clinical outcomes, patient satisfaction, and cost-effectiveness. This transition supports the adoption of advanced cardiovascular devices that offer superior long-term benefits, reduce complication rates, and minimize hospital readmissions—core objectives of value-based care models.
Cardiovascular repair and reconstruction devices designed to enhance surgical precision, reduce procedural risks, and accelerate recovery are becoming more attractive to both providers and payers. Devices such as biocompatible patches, annuloplasty systems, and vascular grafts that contribute to better patient outcomes align with value-based reimbursement incentives and performance-based hospital metrics. As a result, stakeholders are more inclined to invest in high-quality technologies that demonstrate measurable health and economic benefits.
This paradigm shift also encourages closer collaboration between manufacturers, healthcare providers, and payers to ensure device effectiveness is demonstrated through real-world evidence. Outcomes data supporting durability, functionality, and quality of life improvements strengthens the case for reimbursement and widespread clinical adoption. Companies that proactively support data generation and value-based outcomes reporting are better positioned to capitalize on this emerging opportunity.
As healthcare priorities evolve to focus on sustainability, efficiency, and patient-centered care, the demand for advanced cardiovascular repair and reconstruction devices that support value-based models is expected to grow. Manufacturers that integrate innovation with outcome-focused solutions will be at the forefront of this transformation, driving market expansion and improved standards of care worldwide.
Cardiovascular Repair And Reconstruction Devices Market Competitive Landscape Analysis
Cardiovascular Repair And Reconstruction Devices Market is witnessing robust growth driven by strategic partnerships, collaboration, and continuous innovation in medical devices. Leading companies leverage technological advancements and merger activities to expand product portfolios. Approximately 60% of market adoption is captured by advanced repair and reconstruction devices, reflecting the importance of safety, efficacy, and brand trust.
Market Structure and Concentration
The market exhibits moderate concentration, with top medical device manufacturers controlling around 65% of the share. Smaller firms enter through niche cardiovascular solutions, while major enterprises dominate hospital and clinical distribution channels. Strategic mergers and collaborative strategies enhance operational efficiency, driving growth and strengthening competitive positioning in the cardiovascular repair and reconstruction devices market.
Brand and Channel Strategies
Nearly 55% of companies focus on strong brand positioning and multichannel strategies to maximize visibility. Partnerships with hospitals, clinics, and healthcare providers expand market reach. Continuous innovation in device design, minimally invasive procedures, and post-operative care strengthens brand equity, supporting sustained growth across key regions.
Innovation Drivers and Technological Advancements
Technological advancements drive over 50% of new product developments. Continuous innovation in implantable devices, bioengineering, and surgical techniques reshapes patient outcomes. Strategic collaboration with research institutions accelerates device development, ensuring sustainable growth and enhancing competitive advantage for leading cardiovascular device manufacturers.
Regional Momentum and Expansion
Regional expansion strategies are critical, with collaborations and partnerships increasing market presence by approximately 58%. Companies implement tailored strategies to meet local healthcare infrastructure and regulatory requirements. Technological advancements and strategic alliances improve device availability and procedural efficiency, reinforcing competitive growth in both mature and emerging markets.
Future Outlook
The market’s future outlook remains positive, supported by ongoing innovation, strategic partnerships, and merger activities. Focused growth strategies and technological advancements are expected to redefine cardiovascular repair and reconstruction standards. Over 60% of stakeholders emphasize patient safety, innovation, and efficacy, reinforcing long-term resilience, competitive advantage, and market expansion.
Key players in Cardiovascular Repair And Reconstruction Devices Market include:
- Medtronic plc
- Becton Dickinson (BD)
- Terumo Corporation
- W. L. Gore & Associates, Inc.
- Getinge AB
- Artivion, Inc.
- Edwards Lifesciences Corporation
- CryoLife, Inc.
- LeMaitre Vascular
- Bard Peripheral Vascular (BD subsidiary)
- Johnson & Johnson (Medical Devices division)
- Admedus Ltd.
- Maquet / Getinge (cardiovascular surgery division)
- St. Jude Medical / Abbott
- Reverse Medical Corporation
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Raw Material
- Market Snapshot, By Region
- Cardiovascular Repair And Reconstruction Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising adoption of diagnostic & monitoring tools
- Prevalence of Cardiovascular Diseases
- Increasing Awareness and Diagnosis
- Government Initiatives and Healthcare Policies
- Restraints
-
Expensive Medical Procedure Costs
-
Strict Regulatory Compliance Requirements
-
Inadequate Reimbursement Policy Support
-
- Opportunities
- Surge in minimally invasive & outpatient procedures
- Focus on Patient-Centric Approaches
- Collaborations and Partnerships
- Telemedicine and Remote Monitoring
- Shift towards Value-Based Healthcare
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Cardiovascular Repair and Reconstruction Devices Market, By Product, 2021 - 2031 (USD Million)
- Heart Valve Repair
- Cardiovascular Grafts
- Endovascular Stent Graft
- Hemodialysis Access Graft
- Peripheral Vascular Graft
- Cardiovascular Patches
- Cardiovascular Repair and Reconstruction Devices Market, By Application, 2021 - 2031 (USD Million)
- Cardiac Repair Patches
- Atrial Septal Defect
- Common Atrium
- Defects of the Endocardial Cushion
- Ventricular Septal Defect
- Tetralogy of Fallot
- Suture Bleeding
- Vascular Repair Patches
- Carotid Endarterectomy
- Anomalous Connection of the Pulmonary Veins
- Transportation of the Great Vessels
- Reconstruction of the Portal & Superior Mesenteric Veins
- Others
- Cardiac Repair Patches
- Cardiovascular Repair and Reconstruction Devices Market, By Raw Material, 2021 - 2031 (USD Million)
- Synthetic Patches
- Biological Patches
- Cardiovascular Repair And Reconstruction Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Cardiovascular Repair and Reconstruction Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Medtronic plc
- Becton Dickinson (BD)
- Terumo Corporation
- W. L. Gore & Associates, Inc.
- Getinge AB
- Artivion, Inc.
- Edwards Lifesciences Corporation
- CryoLife, Inc.
- LeMaitre Vascular
- Bard Peripheral Vascular (BD subsidiary)
- Johnson & Johnson (Medical Devices division)
- Admedus Ltd.
- Maquet / Getinge (cardiovascular surgery division)
- St. Jude Medical / Abbott
- Reverse Medical Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market